NEW
Stock Screener with Intrinsic Value
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$696.9(5.0%)
Market Cap$75.6B
26.7%
Industry median - (125.1%)
5Y Historical average - 45.0%
19.8%
Industry median - (131.8%)
5Y Historical average - 39.3%
16.2%
Industry median - (52.2%)
5Y Historical average - 26.5%
11.1%
Industry median - (51.2%)
5Y Historical average - 21.1%
REGN Capital Allocation Rating
Crunching data... Almost there!
REGN Capital Allocation metrics
Crunching data... Almost there!
Competing with REGN Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Regeneron Pharmaceuticals, Inc. (REGN) ROIC (Return on Invested Capital)?
The Regeneron Pharmaceuticals, Inc. (REGN) ROIC is 26.7%, compared to the industry median of ((125.1%)) and the 5-year historical average of 45.0%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) ROIC minus WACC (Weighted Average Cost of Capital)?
The Regeneron Pharmaceuticals, Inc. (REGN) ROIC minus WACC is 19.8%, compared to the industry median of ((131.8%)) and the 5-year historical average of 39.3%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) ROE (Return on Equity)?
The Regeneron Pharmaceuticals, Inc. (REGN) ROE is 16.2%, compared to the industry median of ((52.2%)) and the 5-year historical average of 26.5%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) ROCE (Return on Capital Employed)?
The Regeneron Pharmaceuticals, Inc. (REGN) ROCE is 11.1%, compared to the industry median of ((51.2%)) and the 5-year historical average of 21.1%.